Menopause and metabolic syndrome in the Middle East countries; a systematic review and meta-analysis study

go back to reference National cholesterol education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III): third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adult final report. Circulation 2002; 106:3143–3421. National cholesterol education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III): third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adult final report. Circulation 2002; 106:3143–3421.

go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on Epidemiology and Prevention., Hational Heart, Lung, and Blood Institute., American Heart Association., World Heart Federation., International Atherosclerosis Society., International Association for the Study of Obesity.; International diabetes federation task force on epidemiology and prevention; Hational heart, lung, and blood institute; American Heart Association; world heart federation; international atherosclerosis society; International Association for the Study of obesity. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation 2009;120(16):1640–5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on Epidemiology and Prevention., Hational Heart, Lung, and Blood Institute., American Heart Association., World Heart Federation., International Atherosclerosis Society., International Association for the Study of Obesity.; International diabetes federation task force on epidemiology and prevention; Hational heart, lung, and blood institute; American Heart Association; world heart federation; international atherosclerosis society; International Association for the Study of obesity. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation 2009;120(16):1640–5. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​109.​192644.​

go back to reference Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and nutrition examination survey. JAMA. 2002;287(3):356–9.CrossRefPubMed Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and nutrition examination survey. JAMA. 2002;287(3):356–9.CrossRefPubMed

go back to reference Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care. 2011;34(1):216–9. https://doi.org/10.2337/dc10-0879.CrossRefPubMed Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care. 2011;34(1):216–9. https://​doi.​org/​10.​2337/​dc10-0879.CrossRefPubMed

go back to reference Meigs JB, Nathan DM, Wolfsdorf JI, Mulder JE. The metabolic syndrome (insulin resistance syndrome or syndrome X). Available at: www.UpToDate.com. Last updated: Jan 13, 2017. Meigs JB, Nathan DM, Wolfsdorf JI, Mulder JE. The metabolic syndrome (insulin resistance syndrome or syndrome X). Available at: www.​UpToDate.​com. Last updated: Jan 13, 2017.

go back to reference Tabatabaei-Malazy O, Fakhrzadeh H, Sharifi F, Mirarefin M, Badamchizadeh Z, Larijani B. Gender differences in association between metabolic syndrome and carotid intima media thickness. J Diabetes Metab Disord. 2012;11(1):13. https://doi.org/10.1186/2251-6581-11-13.CrossRefPubMedPubMedCentral Tabatabaei-Malazy O, Fakhrzadeh H, Sharifi F, Mirarefin M, Badamchizadeh Z, Larijani B. Gender differences in association between metabolic syndrome and carotid intima media thickness. J Diabetes Metab Disord. 2012;11(1):13. https://​doi.​org/​10.​1186/​2251-6581-11-13.CrossRefPubMedPubMedCentral

go back to reference McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385–90.CrossRefPubMed McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385–90.CrossRefPubMed

go back to reference Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas. 2010;65:262–6. https://doi.org/10.1016/j.maturitas.2009.11.004.CrossRefPubMed Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas. 2010;65:262–6. https://​doi.​org/​10.​1016/​j.​maturitas.​2009.​11.​004.CrossRefPubMed

go back to reference van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14:9. https://doi.org/10.1186/1472-6823-14-9.CrossRefPubMedPubMedCentral van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14:9. https://​doi.​org/​10.​1186/​1472-6823-14-9.CrossRefPubMedPubMedCentral

go back to reference de Carvalho Vidigal F, Bressan J, Babio N, Salas-Salvadó J. Prevalence of metabolic syndrome in Brazilian adults: a systematic review. BMC Public Health. 2013;13:1198. https://doi.org/10.1186/1471-2458-13-1198.CrossRefPubMedPubMedCentral de Carvalho Vidigal F, Bressan J, Babio N, Salas-Salvadó J. Prevalence of metabolic syndrome in Brazilian adults: a systematic review. BMC Public Health. 2013;13:1198. https://​doi.​org/​10.​1186/​1471-2458-13-1198.CrossRefPubMedPubMedCentral

go back to reference Amirkalali B, Fakhrzadeh H, Sharifi F, Kelishadi R, Zamani F, Asayesh H, et al. Prevalence of metabolic syndrome and its components in the Iranian adult population: a systematic review and meta-analysis. Iran Red Crescent Med J. 2015;17(12):e24723. https://doi.org/10.5812/ircmj.24723. Amirkalali B, Fakhrzadeh H, Sharifi F, Kelishadi R, Zamani F, Asayesh H, et al. Prevalence of metabolic syndrome and its components in the Iranian adult population: a systematic review and meta-analysis. Iran Red Crescent Med J. 2015;17(12):e24723. https://​doi.​org/​10.​5812/​ircmj.​24723.​

go back to reference Mendes KG, Theodoro H, Rodrigues AD, Olinto MT. Prevalence of metabolic syndrome and its components in the menopausal transition: a systematic review. Cad Saude Publica. 2012;28(8):1423–37.CrossRefPubMed Mendes KG, Theodoro H, Rodrigues AD, Olinto MT. Prevalence of metabolic syndrome and its components in the menopausal transition: a systematic review. Cad Saude Publica. 2012;28(8):1423–37.CrossRefPubMed

go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analysesthe PRISMA statement. BMJ. 2009;339:b2535. https://doi.org/10.1136/bmj.b2535.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analysesthe PRISMA statement. BMJ. 2009;339:b2535. https://​doi.​org/​10.​1136/​bmj.​b2535.CrossRefPubMedPubMedCentral

go back to reference Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab. 2009;94(4):1104–10. https://doi.org/10.1210/jc.2008-0701. Lee CG, Carr MC, Murdoch SJ, Mitchell E, Woods NF, Wener MH, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab. 2009;94(4):1104–10. https://​doi.​org/​10.​1210/​jc.​2008-0701.

go back to reference Heidari R, Sadeghi M, Talaei M, Rabiei K, Mohammadifard N, Sarrafzadegan N. Metabolic syndrome in menopausal transition: Isfahan healthy heart program, a population based study. Diabetol Metab Syndr. 2010;2:59. https://doi.org/10.1186/1758-5996-2-59.CrossRefPubMedPubMedCentral Heidari R, Sadeghi M, Talaei M, Rabiei K, Mohammadifard N, Sarrafzadegan N. Metabolic syndrome in menopausal transition: Isfahan healthy heart program, a population based study. Diabetol Metab Syndr. 2010;2:59. https://​doi.​org/​10.​1186/​1758-5996-2-59.CrossRefPubMedPubMedCentral

go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9. https://doi.org/10.1016/j.ijsu.2014.07.013. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9. https://​doi.​org/​10.​1016/​j.​ijsu.​2014.​07.​013.

go back to reference Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRefPubMedPubMedCentral Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRefPubMedPubMedCentral

go back to reference Ainy E, Mirmiran P, Zahedi Asl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran lipid and glucose study (TLGS). Maturitas. 2007;58(2):150–5.CrossRefPubMed Ainy E, Mirmiran P, Zahedi Asl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran lipid and glucose study (TLGS). Maturitas. 2007;58(2):150–5.CrossRefPubMed

go back to reference Ozdemir S, Celik C, Görkemli H, Kiyici A, Kaya B. Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome. Int J Gynaecol Obstet. 2009;106(1):57–61. https://doi.org/10.1016/j.ijgo.2009.03.016.CrossRefPubMed Ozdemir S, Celik C, Görkemli H, Kiyici A, Kaya B. Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome. Int J Gynaecol Obstet. 2009;106(1):57–61. https://​doi.​org/​10.​1016/​j.​ijgo.​2009.​03.​016.CrossRefPubMed

go back to reference Ebrahimpour P, Fakhrzadeh H, Heshmat R, Ghodsi M, Bandarian F, Larijani B. Metabolic syndrome and menopause: a population-based study. Diabetes Metab Syndr. 2010;4:5–9. https://doi.org/10.1016/j.dsx.2008.04.014.CrossRef Ebrahimpour P, Fakhrzadeh H, Heshmat R, Ghodsi M, Bandarian F, Larijani B. Metabolic syndrome and menopause: a population-based study. Diabetes Metab Syndr. 2010;4:5–9. https://​doi.​org/​10.​1016/​j.​dsx.​2008.​04.​014.CrossRef

go back to reference Nabipour I, Kalantarhormozi M, Larijani B, Assadi M, Sanjdideh Z. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. Metabolism. 2010;59(5):742–7. https://doi.org/10.1016/j.metabol.2009.09.019.CrossRefPubMed Nabipour I, Kalantarhormozi M, Larijani B, Assadi M, Sanjdideh Z. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. Metabolism. 2010;59(5):742–7. https://​doi.​org/​10.​1016/​j.​metabol.​2009.​09.​019.CrossRefPubMed

go back to reference Akbulut G. Does the prevalence of metabolic syndrome in pre- and post-menopausal women differ by the ATP III and IDF criteria? Turkiye Klinikleri J Med Sci. 2011;31(6):1463–70.CrossRef Akbulut G. Does the prevalence of metabolic syndrome in pre- and post-menopausal women differ by the ATP III and IDF criteria? Turkiye Klinikleri J Med Sci. 2011;31(6):1463–70.CrossRef

go back to reference Ziaei S, Sayahi M, Faghihzadeh S. Relationship between reproductive aging, body composition, hormonal status and metabolic syndrome in postmenopausal women. Climacteric. 2011;14(6):649–53. https://doi.org/10.3109/13697137.2011.570386.CrossRefPubMed Ziaei S, Sayahi M, Faghihzadeh S. Relationship between reproductive aging, body composition, hormonal status and metabolic syndrome in postmenopausal women. Climacteric. 2011;14(6):649–53. https://​doi.​org/​10.​3109/​13697137.​2011.​570386.CrossRefPubMed

go back to reference Marjani A, Moghasemi S. The metabolic syndrome among postmenopausal women in Gorgan. Int J Endocrinol. 2012;2012:1–6. https://doi.org/10.1155/2012/953627.CrossRef Marjani A, Moghasemi S. The metabolic syndrome among postmenopausal women in Gorgan. Int J Endocrinol. 2012;2012:1–6. https://​doi.​org/​10.​1155/​2012/​953627.CrossRef

go back to reference Yoldemir T, Erenus M. The prevalence of metabolic syndrome in pre- and post-menopausal women attending a tertiary clinic in Turkey. Eur J Obstet Gynecol Reprod Biol. 2012;164(2):172–5. https://doi.org/10.1016/j.ejogrb.2012.06.021.CrossRefPubMed Yoldemir T, Erenus M. The prevalence of metabolic syndrome in pre- and post-menopausal women attending a tertiary clinic in Turkey. Eur J Obstet Gynecol Reprod Biol. 2012;164(2):172–5. https://​doi.​org/​10.​1016/​j.​ejogrb.​2012.​06.​021.CrossRefPubMed

go back to reference Aydin M, Koca C, Ozol D, Uysal S, Yildirim Z, Kavakli HS, et al. Interaction of metabolic syndrome with asthma in postmenopausal women: role of adipokines. Inflammation. 2013;36(6):1232–8. https://doi.org/10.1007/s10753-013-9660-9. Aydin M, Koca C, Ozol D, Uysal S, Yildirim Z, Kavakli HS, et al. Interaction of metabolic syndrome with asthma in postmenopausal women: role of adipokines. Inflammation. 2013;36(6):1232–8. https://​doi.​org/​10.​1007/​s10753-013-9660-9.

go back to reference Maharlouei N, Bellissimo N, Ahmadi SM, Lankarani KB. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women. Climacteric. 2013;16(5):561–7. https://doi.org/10.3109/13697137.2012.727504.CrossRefPubMed Maharlouei N, Bellissimo N, Ahmadi SM, Lankarani KB. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women. Climacteric. 2013;16(5):561–7. https://​doi.​org/​10.​3109/​13697137.​2012.​727504.CrossRefPubMed

go back to reference Sarrafzadegan N, Khosravi-Boroujeni H, Esmaillzadeh A, Sadeghi M, Rafieian-Kopaei M, Asgary S. The association between hypertriglyceridemic waist phenotype, menopause, and cardiovascular risk factors Arch Iran Med 2013;16(3):161–166. 013163/AIM.008. Sarrafzadegan N, Khosravi-Boroujeni H, Esmaillzadeh A, Sadeghi M, Rafieian-Kopaei M, Asgary S. The association between hypertriglyceridemic waist phenotype, menopause, and cardiovascular risk factors Arch Iran Med 2013;16(3):161–166. 013163/AIM.008.

go back to reference Sunbul M, Eren F, Nacar C, Agirbasli M. Sex hormone binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women. Cardiol J. 2013;20(3):287–93. https://doi.org/10.5603/CJ.2013.0074.CrossRefPubMed Sunbul M, Eren F, Nacar C, Agirbasli M. Sex hormone binding globulin gene polymorphisms and metabolic syndrome in postmenopausal Turkish women. Cardiol J. 2013;20(3):287–93. https://​doi.​org/​10.​5603/​CJ.​2013.​0074.CrossRefPubMed

go back to reference Caglar GS, Ozdemir ED, Kiseli M, Demirtas S, Cengiz SD. The association of osteocalcin and adiponectin with glucose metabolism in nondiabetic postmenopausal women. Gynecol Obstet Investig. 2014;77(4):255–60. https://doi.org/10.1159/000358826.CrossRef Caglar GS, Ozdemir ED, Kiseli M, Demirtas S, Cengiz SD. The association of osteocalcin and adiponectin with glucose metabolism in nondiabetic postmenopausal women. Gynecol Obstet Investig. 2014;77(4):255–60. https://​doi.​org/​10.​1159/​000358826.CrossRef

go back to reference Yildiz S, Toprak H, Aydin S, Bilgin M, Oktay V, Abaci O, et al. The association of breast arterial calcification and metabolic syndrome. Clinics (Sao Paulo). 2014;69:841–6. https://doi.org/10.6061/clinics/2014(12)09. Yildiz S, Toprak H, Aydin S, Bilgin M, Oktay V, Abaci O, et al. The association of breast arterial calcification and metabolic syndrome. Clinics (Sao Paulo). 2014;69:841–6. https://​doi.​org/​10.​6061/​clinics/​2014(12)09.

go back to reference Terzi R, Dindar S, Terzi H, Demirtas O. Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia. Metab Syndr Relat Disord. 2015;13:78–83. https://doi.org/10.1089/met.2014.0074.CrossRefPubMed Terzi R, Dindar S, Terzi H, Demirtas O. Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia. Metab Syndr Relat Disord. 2015;13:78–83. https://​doi.​org/​10.​1089/​met.​2014.​0074.CrossRefPubMed

go back to reference Abbasi M, Farzam SA, Mamaghani Z, Yazdi Z. Relationship between metabolic syndrome and its components with bone densitometry in postmenopausal women. Diabetes Metab Syndr 2016; pii: s1871–4021 (16) 30230–2. https://doi.org/10.1016/j.dsx.2016.12.008. Abbasi M, Farzam SA, Mamaghani Z, Yazdi Z. Relationship between metabolic syndrome and its components with bone densitometry in postmenopausal women. Diabetes Metab Syndr 2016; pii: s1871–4021 (16) 30230–2. https://​doi.​org/​10.​1016/​j.​dsx.​2016.​12.​008.

go back to reference Namazi Shabestari A, Asadi M, Jouyandeh Z, Qorbani M, Kelishadi R. Association of lipid accumulation product with cardio-metabolic risk factors in postmenopausal women. Acta Med Iran. 2016;54:370–5.PubMed Namazi Shabestari A, Asadi M, Jouyandeh Z, Qorbani M, Kelishadi R. Association of lipid accumulation product with cardio-metabolic risk factors in postmenopausal women. Acta Med Iran. 2016;54:370–5.PubMed

go back to reference Ozelci R, Dilbaz B, Ozkaya E, Cirik DA, Zengin T, Mollamahmutoglu L. Association between bone mineral density and metabolic syndrome in turkish women who were postmenopausal. Int J Gynaecol Obstet. 2016;133:370–4. https://doi.org/10.1016/j.ijgo.2015.10.010.CrossRefPubMed Ozelci R, Dilbaz B, Ozkaya E, Cirik DA, Zengin T, Mollamahmutoglu L. Association between bone mineral density and metabolic syndrome in turkish women who were postmenopausal. Int J Gynaecol Obstet. 2016;133:370–4. https://​doi.​org/​10.​1016/​j.​ijgo.​2015.​10.​010.CrossRefPubMed

go back to reference Indhavivadhana S, Rattanachaiyanont M, Wongvananurak T, Kanboon M, Techatraisak K, Leerasiri P, et al. Predictors for metabolic syndrome in perimenopausal and postmenopausal Thai women. Climacteric. 2011;14:58–65. Indhavivadhana S, Rattanachaiyanont M, Wongvananurak T, Kanboon M, Techatraisak K, Leerasiri P, et al. Predictors for metabolic syndrome in perimenopausal and postmenopausal Thai women. Climacteric. 2011;14:58–65.

go back to reference Joo JK, Son JB, Ju Eun Jung JE, Kim SC, Lee KS. Differences of prevalence and components of metabolic syndrome according to menopausal status. J Korean Soc Menopause. 2012;18:155–62. https://doi.org/10.6118/jksm2012.18.3.155.CrossRef Joo JK, Son JB, Ju Eun Jung JE, Kim SC, Lee KS. Differences of prevalence and components of metabolic syndrome according to menopausal status. J Korean Soc Menopause. 2012;18:155–62. https://​doi.​org/​10.​6118/​jksm2012.​18.​3.​155.CrossRef

go back to reference Marchi R, Dell’Agnolo CM, Lopes TCR, Gravena AAF, Demitto MO, Brischiliari SCR, et al. Prevalence of metabolic syndrome in pre- and postmenopausal women. Arch Endocrinol Metab. 2017;61:160–6. https://doi.org/10.1590/2359-3997000000253. Marchi R, Dell’Agnolo CM, Lopes TCR, Gravena AAF, Demitto MO, Brischiliari SCR, et al. Prevalence of metabolic syndrome in pre- and postmenopausal women. Arch Endocrinol Metab. 2017;61:160–6. https://​doi.​org/​10.​1590/​2359-3997000000253.

go back to reference Liang H, Chen X, Chen Q, Wang Y, Wu X, Li Y, et al. The metabolic syndrome among postmenopausal women in reral Canton: prevalence, associated factors, and the optimal obesity and atherogenic indices. PLoS One. 2013;8:e74121. https://doi.org/10.1371/journal.pone.0074121. Liang H, Chen X, Chen Q, Wang Y, Wu X, Li Y, et al. The metabolic syndrome among postmenopausal women in reral Canton: prevalence, associated factors, and the optimal obesity and atherogenic indices. PLoS One. 2013;8:e74121. https://​doi.​org/​10.​1371/​journal.​pone.​0074121.

go back to reference Ben Ali S, Belfki0Benali H, Aounallah-Skhiri H, Traissac P, Maire B, Delpeuch F, Achour N, Ben Romdhane H. Menopause and metabolic syndrome in Tunisian women. Biomed Res Int 2014; 2014: 457131. https://doi.org/10.1155/2014/457131, 1, 7. Ben Ali S, Belfki0Benali H, Aounallah-Skhiri H, Traissac P, Maire B, Delpeuch F, Achour N, Ben Romdhane H. Menopause and metabolic syndrome in Tunisian women. Biomed Res Int 2014; 2014: 457131. https://​doi.​org/​10.​1155/​2014/​457131, 1, 7.

go back to reference Sharma S, aggarwal N, joshi B, Suri V, Badada S. Prevalence of metabolic syndrome in pre- and post-menopausal women: a prospective study from apex institute of North India. J Midlife health. 2016;7:169–74. https://doi.org/10.4103/0976-7800.195695.CrossRefPubMedPubMedCentral Sharma S, aggarwal N, joshi B, Suri V, Badada S. Prevalence of metabolic syndrome in pre- and post-menopausal women: a prospective study from apex institute of North India. J Midlife health. 2016;7:169–74. https://​doi.​org/​10.​4103/​0976-7800.​195695.CrossRefPubMedPubMedCentral

go back to reference Sapkota ASH, Sapkota A, Acharya K, Raut M, Jha B. Study of metabolic syndrome in postmenopausal women. Ann Clin Chem Lab Med 2015: 1: 6–11. https://doi.org/10.3126/acclm.vlil.12307. Sapkota ASH, Sapkota A, Acharya K, Raut M, Jha B. Study of metabolic syndrome in postmenopausal women. Ann Clin Chem Lab Med 2015: 1: 6–11. https://​doi.​org/​10.​3126/​acclm.​vlil.​12307.

go back to reference Orgaz Gallego MP, Bermejo Lopez P, Tricio Armero MA, Abellan Aleman J, Solera Albero J, Tarraga Lopez PJ. Metabolic syndrome and its components in postmenopausal women. Nutr Hosp. 2015;32:656–66. https://doi.org/10.3305/nh.2015.32.2.9211. CrossRefPubMed Orgaz Gallego MP, Bermejo Lopez P, Tricio Armero MA, Abellan Aleman J, Solera Albero J, Tarraga Lopez PJ. Metabolic syndrome and its components in postmenopausal women. Nutr Hosp. 2015;32:656–66. https://​doi.​org/​10.​3305/​nh.​2015.​32.​2.​9211.​ CrossRefPubMed

go back to reference Ebtekar F, Dalvand S, Gheshlagh RG. The prevalence of metabolic syndrome in postmenopausal women: a systematic review and meta-analysis in Iran. Diabetes Metab Syndr. 2018;12(6):955–60. https://doi.org/10.1016/j.dsx.2018.06.002.CrossRefPubMed Ebtekar F, Dalvand S, Gheshlagh RG. The prevalence of metabolic syndrome in postmenopausal women: a systematic review and meta-analysis in Iran. Diabetes Metab Syndr. 2018;12(6):955–60. https://​doi.​org/​10.​1016/​j.​dsx.​2018.​06.​002.CrossRefPubMed

go back to reference Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32(6):1092–7. https://doi.org/10.2337/dc08-1800.CrossRefPubMedPubMedCentral Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009;32(6):1092–7. https://​doi.​org/​10.​2337/​dc08-1800.CrossRefPubMedPubMedCentral

go back to reference Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20–70 years, in the north of Iran: a population-based study and regression approach. Obes Rev. 2007;8(1):3–10.CrossRefPubMed Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20–70 years, in the north of Iran: a population-based study and regression approach. Obes Rev. 2007;8(1):3–10.CrossRefPubMed

go back to reference Dalvand S, Niksima SH, Meshkani R, Ghanei Gheshlagh R, Sadegh-Nejadi S, Kooti W, et al. Prevalence of metabolic syndrome among Iranian population: a systematic review and meta-analysis. Iran J Public Health. 2017;46:456–67. Dalvand S, Niksima SH, Meshkani R, Ghanei Gheshlagh R, Sadegh-Nejadi S, Kooti W, et al. Prevalence of metabolic syndrome among Iranian population: a systematic review and meta-analysis. Iran J Public Health. 2017;46:456–67.

go back to reference Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in Iran: a systematic review and meta-analysis study. Int J Prev Med. 2014;5:373–93.PubMedPubMedCentral Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in Iran: a systematic review and meta-analysis study. Int J Prev Med. 2014;5:373–93.PubMedPubMedCentral

go back to reference Qorbani M, Tabatabaei-Malazy O, Kelishadi R, Larijani B. Mean serum lipid levels in Iranian adult populations: a systematic review and meta-analysis. Clin Lipidol. 2015;10(5):449–64.CrossRef Qorbani M, Tabatabaei-Malazy O, Kelishadi R, Larijani B. Mean serum lipid levels in Iranian adult populations: a systematic review and meta-analysis. Clin Lipidol. 2015;10(5):449–64.CrossRef

go back to reference IDF diabetes atlas-7th edition. Available at: http://www.diabetesatlas.org. Last accessed: 21 Oct 2017. IDF diabetes atlas-7^th edition. Available at: http://​www.​diabetesatlas.​org. Last accessed: 21 Oct 2017.

go back to reference Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980-2012: a systematic review. J Tehran heart Cent. 2016;11:159–67.PubMedPubMedCentral Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980-2012: a systematic review. J Tehran heart Cent. 2016;11:159–67.PubMedPubMedCentral

go back to reference Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al. Turkish Society of Hypertension and Renal Diseases. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016;34:1208–17. https://doi.org/10.1097/HJH.0000000000000901. Sengul S, Akpolat T, Erdem Y, Derici U, Arici M, Sindel S, et al. Turkish Society of Hypertension and Renal Diseases. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016;34:1208–17. https://​doi.​org/​10.​1097/​HJH.​0000000000000901​.​

go back to reference Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in gulf cooperation council countries: a systematic review. Diabet Med. 2010;27(5):593–7.CrossRefPubMed Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in gulf cooperation council countries: a systematic review. Diabet Med. 2010;27(5):593–7.CrossRefPubMed

go back to reference IDF consensus worldwide definition of the metabolic syndrome. Available at: https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome. Last accessed: 21 Oct 2017. IDF consensus worldwide definition of the metabolic syndrome. Available at: https://​www.​idf.​org/​e-library/​consensus-statements/​60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome. Last accessed: 21 Oct 2017.